Caspase 1–deficient humans survive into late adulthood despite dramatically lower canonical inflammasome activity is a research paper published in Journal of Allergy and Clinical Immunology (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01-HG-010689
National Institutes of Health
Grant: RC1 TW008485-01
National Institutes of Health
Grant: R01-HL133339
National Institutes of Health
Grant: R01-HL-145437
National Institutes of Health
Grant: X01HL139399
National Institutes of Health
Grant: RC2 HL101834-01
Astellas Pharma US
AstraZeneca
FWCI
0.80
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords